Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Spain- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain366 clinical trials in Palma, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on chronic respiratory conditions, including groundbreaking research on treatments for asthma and COPD. Studies evaluate innovative therapies like tezepelumab and lunsekimig to manage symptoms and reduce exacerbations.
Research aims to improve patient outcomes through targeted therapeutic approaches.
Comprehensive studies on various cancer types, with particular focus on blood cancers and solid tumors. Investigations include innovative combination therapies and novel treatment approaches for lymphomas and leukemias.
Trials evaluate both conventional and emerging therapeutic strategies.
Research focusing on heart conditions and related disorders, including studies on hypertrophic cardiomyopathy and anticoagulation therapies. Trials evaluate new medications and treatment approaches for various cardiac conditions.
Studies aim to improve cardiac function and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.